Search Medical Condition
Please enter condition
Please choose location from dropdown

Eczema (Atopic Dermatitis - Pediatric) Clinical Trials

A listing of Eczema (Atopic Dermatitis - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (15) clinical trials

The purpose of this study is to evaluate the safety and tolerability of topical INCB018424 cream applied to pediatric subjects (≥ 12 to 17 years) with atopic dermatitis (AD).

Phase

Wake Research Associates is enrolling volunteers with eczema in a clinical research study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

Do you or your child suffer from eczema, also known as atopic dermatitis? Wake Research Associates is enrolling volunteers in a clinical research study testing two, study-related creams to a placebo for individuals with eczema.

Phase N/A

This research study will evaluate the effectiveness and safety of two concentrations (0.5 percent [%] and 1%) and two application frequencies (once a day and twice a day) of GSK2894512 cream for the topical treatment in adolescent and adult subjects with atopic dermatitis (eczema). Results from this study will be ...

Phase

Do you or your child suffer from Atopic Dermatitis or Eczema?

Phase

This voluntary study is testing an investigational medicine, called IDP-124, to see if it is safe to use on individuals 12 and older who have Moderate to Severe Atopic Dermatitis. WHAT WILL HAPPEN TO ME IN THIS STUDY? If you are able to be in the study, you, your parent(s) ...

Phase

This study will be testing an investigational medication for the treatment of atopic dermatitis

Phase

The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...

Phase

This is a double-blind, randomized, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of Tralokinumab for the treatment of moderate to severe Atopic Dermatitis. All enrolled participants will receive subcutaneous injections of medication every two weeks for 52 weeks. There are 16 in-office visits throughout the study and ...

Phase

This is a multicenter double-blind, randomized, placebo-controlled study to assess the efficacy and safety of IDP-124 lotion for the treatment of moderate to severe atopic dermatitis (eczema). All enrolled subjects will receive a lotion medication to be applied twice daily for 6 weeks. There are 7 office visits throughout the ...

Phase